NR565 WK 6 Asthma1 Asthma Treatment Algorithm: To successfully treat asthma, you must first classify it and then be familiar with step therapy.For this assignment and in this course, we will focus on patients 12 years and older. Complete the blanks in the following table to create an algorithm for asthma care using your textbook as well asGINA guidelines. StepAsthmaClassificationAsthma symptoms and frequency asnoted in textbookController and PreferredReliever:(Drug Class and frequency ifprovided from GINA guidelines)Controller and Alternative Reliever: (Drug Class and frequency if provided from GINA guidelines) Step 1Intermittent Daytime symptoms 2 d/wk or less Drug class:Low dose ICS- formoterol Frequency:As-needed Drug class:Take ICS Frequency:when SABA is taken Nighttimeawakenings 2 times/month or less Step 2Mild Persistent DaytimesymptomsMore than 2 d/wk but less than daily Drug class: Low dose maintence ICS Nighttime awakenings 3–4 times/month Step 3ModeratePersistentDaytime symptoms Daily Drug class: Low dose maintenance ICS- formoterol Drug class: Low dose maintence ICS-LABA NighttimeawakeningsMore than once/week butless than nightly Step4-5SeverePersistentDaytime symptoms Several time dailyStep 4: Drug class:Medium dose maintenance ICS-formoterol Drug class: High/medium dose ICS-LABA NighttimeawakeningsOften nightlyStep 5:Drug class:Add LAMA, & consider high dose ICS-formoterol Refer for:phenotypic assessment,No change.

NR565 WK 6 Asthma2 +/- anti-IgE, anti-IL5/R5, anti-IL4R, & consider high dose ICS- formoterol Starting treatment: Complete this section using the GINA guidelines provided. First Assess: 1.Confirm diagnosis 2.Symptom control 3.Modifiable risk factors 4.Comorbidities 5.Inhaler technique & adherance 6.Patient preferences & goals Fill in the blank: 1. Using ICS-formoterol as reliever reduces the risk of exacerbation compared with using a SABA reliever. 2. Before considering a regimen with a SABA reliever, check if the patient is likely to be adherent with daily controller therapy.